Search Results for ''

published presentations and documents on DocSlides.

DOR + 2 NRTIs vs. DRV + RTV + 2 NRTIs
DOR + 2 NRTIs vs. DRV + RTV + 2 NRTIs
by maximus
DRIVE FORWARD. Doravirine. + 2 NRTIs vs. Darunavi...
NRTI-sparing SPARTAN PROGRESS
NRTI-sparing SPARTAN PROGRESS
by shepard237
RADAR. NEAT001/ANRS 14. 3 . A4001078. VEMAN. MODER...
An update on WHO process, interim guidance and future guidelines. What’s next?  
An update on WHO process, interim guidance and future guidelines. What’s next?  
by palmer
James Kiarie and Petrus Steyn. Human Reproduction ...
David Alain  Wohl , MD Associate Professor of Medicine
David Alain Wohl , MD Associate Professor of Medicine
by hayden600
The University of North Carolina . at Chapel Hill....
New and Investigational ART Drugs and Strategies
New and Investigational ART Drugs and Strategies
by elina
Judith S. Currier, MD, . MSc. Division of Infectio...
Update from CROI 2023: Snippets from Seattle
Update from CROI 2023: Snippets from Seattle
by scarlett
Judith S. Currier, MD, MSc. Professor of Medicine....
ARVs & DDIs in pregnancy
ARVs & DDIs in pregnancy
by obrien
Scientific Workshop. Improving patient care throug...
1 Yale University School of Medicine, New Haven, United States,
1 Yale University School of Medicine, New Haven, United States,
by thomas
2. Icahn School of Medicine at Mount Sinai, New Yo...
Immune correlates analysis of the
Immune correlates analysis of the
by hazel
Imbokodo. HIV-1 vaccine efficacy trial. Late Brea...
Zambia Ureport Case Study:
Zambia Ureport Case Study:
by adah
Designing, Implementing and Managing a T4D strateg...
Cognitive Function among
Cognitive Function among
by tabitha
cART. -treated Children and Adolescents with HIV i...
DTG/3TC 1st line (GEMINI)
DTG/3TC 1st line (GEMINI)
by oryan
ARV . strategies. DOR > DRV/r 1st line. (DRIVE-...
Faculty W. David Hardy, MD, AAHIVS
Faculty W. David Hardy, MD, AAHIVS
by christina
Scientific and Medical Consultant. Adjunct Clinica...
A Vaginal Ring Containing
A Vaginal Ring Containing
by gelbero
Dapivirine. for HIV-1 PrEP. . Ring. A Vaginal Ri...
Passive and Active Immunization
Passive and Active Immunization
by hailey
Nono Mkhize, PhD. National Institute for Communica...
Elvitegravir-Cobicistat-TAF-FTC in Hepatitis B Coinfection
Elvitegravir-Cobicistat-TAF-FTC in Hepatitis B Coinfection
by melanie
Study 1249. Elvitegravir-Cobicistat-TAF-FTC in HIV...
CROI 2019 Scientific summary of the major clinical studies presented at CROI 2019
CROI 2019 Scientific summary of the major clinical studies presented at CROI 2019
by blanko
Résumé scientifique des principales études clin...
Rev Inst Med Trop Sao Paulo
Rev Inst Med Trop Sao Paulo
by anya
55(5):315-321, September-October, 2013 doi: 10.159...
ROLE OF GBV
ROLE OF GBV
by obrien
- C AND HUMAN HERPES VIRUS COINFECTIONS IN AIDS D...
Gulhane Med J 2021632024
Gulhane Med J 2021632024
by roy
20 Pericardial disease was the most frequent clini...
PREVALENCE OF HIVDISCORDANT COUPLES IN SUBSAHARAN AFRICA WHAT HAS C
PREVALENCE OF HIVDISCORDANT COUPLES IN SUBSAHARAN AFRICA WHAT HAS C
by payton
As the HIV-1 epidemic in sub-Saharan Africa (SSA) ...
ARC Journal of Public Health and Community Medicine
ARC Journal of Public Health and Community Medicine
by eloise
Volume 2, Issue 2, 2017, PP 1 - 14 ISSN 2456 - 059...
CENTER FOR DRUG EVALUATION AND RESEARCH  APPLICATION NUMBER
CENTER FOR DRUG EVALUATION AND RESEARCH APPLICATION NUMBER
by belinda
naïve subjects infected with CCR5-tropic HIV-1. ...
Joseph J. Eron, Jr, MD Professor of Medicine and Epidemiology
Joseph J. Eron, Jr, MD Professor of Medicine and Epidemiology
by Hulksmash
The University of North Carolina at Chapel Hill. C...
Update on Hepatitis C SSHA Conference 2015
Update on Hepatitis C SSHA Conference 2015
by Hiphopkid
Daniel Bradshaw. Locum Consultant . GUM/HIV. Brigh...
Prevalence of Human
Prevalence of Human
by samantha
Papilloma. Virus DNA in HIV Positive women in Lag...
Costing & Time & Motion Study of
Costing & Time & Motion Study of
by jade
STD Partner Services in Washington State. Epidemic...
PrEP  Case Studies	 Module 6
PrEP Case Studies Module 6
by bethany
Summary recommendations. …. Oral PrEP containing...
Brad  Hare Nothing to Disclose
Brad Hare Nothing to Disclose
by beatrice
Kaiser Permanente San Francisco Medical Center. Sa...
Task Shifting for Initiation and Monitoring of Antiretroviral
Task Shifting for Initiation and Monitoring of Antiretroviral
by heavin
Therapy for HIV-Infected Adults in Uganda: The SHA...
U EQUALS U: the clinician’s perspective
U EQUALS U: the clinician’s perspective
by pamela
Dr. Laura Waters. Consultant Physician. CNWL, Mor...
Ibalizumab ( Trogarzo ) Prepared by:
Ibalizumab ( Trogarzo ) Prepared by:
by audrey
Brian R. Wood, MD. David Spach, MD. Last Updated: ...
Results of Phase II study of
Results of Phase II study of
by grace3
Durvalumab. in cancer patients with HIV-1 infecti...
Background    Oncogenic  Human
Background Oncogenic Human
by barbara
papillomavirus. (HPV) infections are closely asso...
Perspectives from MSF’s AHD programmes in Africa:
Perspectives from MSF’s AHD programmes in Africa:
by alyssa
Challenges, lessons, and opportunities. Tom Ellman...
Bive Zono et al
Bive Zono et al
by smith
Article PAMJ - 37(302). 02 Dec 2020. - Page nu...
Assessing Adherence of PLHIV  to ART Treatment The case of Yeka and G
Assessing Adherence of PLHIV to ART Treatment The case of Yeka and G
by ivy
1 City in Addis Ababa A Proposal on the CHBC Proje...